Tap to Trade in Gate Square, Win up to 50 GT & Merch!
Click the trading widget in Gate Square content, complete a transaction, and take home 50 GT, Position Experience Vouchers, or exclusive Spring Festival merchandise.
Click the registration link to join
https://www.gate.com/questionnaire/7401
Enter Gate Square daily and click any trading pair or trading card within the content to complete a transaction. The top 10 users by trading volume will win GT, Gate merchandise boxes, position experience vouchers, and more.
The top prize: 50 GT.
. However, the magnitude of the position suggests either Buffett’s personal involvement or his explicit approval. What changed the calculus? When Alphabet traded at less than 20 times forward earnings estimates in mid-2025, it offered exceptional value relative to comparable tech companies and even the broader market index. Simultaneously, the company generated tens of billions in free cash flow quarterly despite substantial investments in AI infrastructure—a combination that proved difficult to ignore.
The Industrial Play: Full Acquisition of OxyChem
Berkshire Hathaway’s $9.7 billion acquisition of OxyChem, Occidental Petroleum’s chemical subsidiary, exemplified another dimension of Warren Buffett’s recent stock purchases strategy: thinking beyond public markets. This wasn’t a conventional stock purchase; it was an entire operations acquisition at an estimated valuation multiple below comparable industry leaders.
The chemicals industry had become unfashionable among mainstream investors, creating a valuation discount Buffett exploited. Equally important, Berkshire maintained its existing position in Occidental Petroleum preferred shares, which continued yielding 8% annually—approximately double the rate offered by Treasury bills. The transaction simultaneously strengthened Berkshire’s 28% stake in Occidental while securing a strategic asset at compelling economics.
The International Bet: Increased Stakes in Japanese Trading Houses
Completing the trio of major acquisitions was Berkshire’s increased investment in Mitsubishi and Mitsui, Japanese trading conglomerates. This category of recent stock purchases proved particularly noteworthy given Buffett’s historical reluctance to venture beyond American borders. His increased exposure to these companies reflected a reality: Japanese equities, even as their price-to-book values climbed toward 1.5 times, still offered superior risk-adjusted returns compared to U.S. large-cap stocks.
This wasn’t pure Buffett instinct—long-time partner Charlie Munger had championed the original five-company Japanese trading house investment back in 2020. Yet Buffett’s decision to continue adding positions in 2025 signaled confidence that international diversification merited attention in an expensive domestic market.
Why These Recent Stock Purchases Matter Beyond the Numbers
The unified lesson threading through Warren Buffett’s recent acquisitions isn’t complicated, but it’s powerful: compelling investments exist in today’s overvalued market if you’re willing to venture beyond conventional territory.
For most retail investors, this requires uncomfortable expansion of their investment circle. Alphabet, while large-cap, represented tech exposure at reasonable prices—requiring conviction in AI’s productivity benefits despite the sector’s frothy valuation. OxyChem meant accepting the industrial sector’s unfashionable status. Japanese trading houses demanded international research and geographic risk tolerance that many portfolio managers instinctively resist.
Yet each offered genuine value because sophisticated analysts—Buffett’s team among them—were willing to do deeper analytical work. Small-cap U.S. equities, European market securities, and Japanese stocks all offered more attractive valuations than the mega-cap American tech-driven indices that dominated retail attention and capital allocation.
The Practical Takeaway for Today’s Investors
Warren Buffett’s recent stock purchases suggest a timeless principle: market inefficiencies persist precisely because most investors follow crowded, comfortable paths. The Oracle of Omaha isn’t necessarily smarter than other participants; he’s willing to look farther afield for value.
That doesn’t mean attempting to replicate Berkshire’s specific moves. Buffett has unequaled access to private transactions like OxyChem and the resources to move billion-dollar positions without market-moving consequences. Smaller investors face different constraints and opportunities.
However, the underlying message from recent stock purchases remains universally applicable: when broad market valuations appear stretched, returns remain achievable by combining deeper research, sector diversification, and international perspective. The work required to identify these opportunities proves inconvenient—which explains why most investors skip it. Yet for those patient enough to undertake rigorous analysis, the decade ahead could deliver exceptional returns, even within a generally expensive market environment.